BrenX (BRNX) filed an 8-K to sell up to $2.89 million in ordinary shares through an at-the-market offering, leading to a significant after-hours stock drop. This offering could dilute existing shareholders by over 50% and raises concerns about the company's financial stability and potential delisting from Nasdaq.
BrenX (BRNX) has filed for an at-the-market offering to sell up to $2.89 million in ordinary shares. This move is highly dilutive, potentially increasing outstanding shares by over 50%, which explains the 30% after-hours price drop. The company's history of multiple reverse stock splits in 2026 and the disclosure about not being eligible for another compliance period if its stock falls below $1.00 for 30 days highlight severe financial distress and a high risk of delisting. This offering is a short-term attempt to raise capital but signals long-term solvency issues and significant downside risk for current shareholders.